Cara Therapeutics (CARA) P/E US GAAP (year values) |
|||||||||
2020 | 2021 | 2022 | 2023 | 2023 | LTM ? | CAGR 5 years ? | |||
P/E | ? | 85.3 | -7.00 | -6.91 | -0.34 | -0.34 | -0.56 | ||
Changes by years, y/y, % | -1 420% | -108% | -1% | -95% | 0% | -44.3% |
Cara Therapeutics. P/E
Cara Therapeutics. P/E, changes, %
Cara Therapeutics (CARA) P/E US GAAP (quarter values) |
||||||||
2023Q3 | 2023Q4 | 2023Q4 | 2024Q1 | 2024Q2 | LTM ? | |||
P/E | ? | -0.80 | -0.34 | -0.34 | -0.41 | -0.13 | -0.56 | |
Changes by years, y/y, % | -86% | -95% | -95% | -88% | -91% | |||
Changes by quarters, q/q, % | -43% | -57% | 0% | +18% | -69% |